Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Arteriosclerosis, Thrombosis, and Vascular Biology. 1989;9:462-469

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franceschini, G.
Right arrow Articles by Sirtori, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franceschini, G.
Right arrow Articles by Sirtori, C. R.

Arteriosclerosis, Vol 9, 462-469, Copyright © 1989 by American Heart Association

ARTICLES

Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer

G Franceschini, M Sirtori, V Vaccarino, G Gianfranceschi, L Rezzonico, G Chiesa and CR Sirtori
Center E. Grossi Paoletti, University of Milano, Italy.

Treatment with probucol, a widely used lipid-lowering agent, is associated with a significant reduction of high density lipoprotein (HDL) cholesterol levels, but with an apparently improved removal of cholesteryl esters from tissues (e.g., from tendon xanthomas). The effects of probucol (500 mg twice daily) on HDL subfraction distribution and cholesteryl ester transfer activity were tested in 12 patients with stable type II hyperlipidemia [low density lipoprotein (LDL) cholesterol greater than 180 mg/dl] after a placebo-controlled cross-over trial. Probucol significantly lowered total cholesterol (- 13.8%), LDL cholesterol (-9.1%), and HDL cholesterol (-30%). By rate zonal ultracentrifugation, a marked reduction of HDL2 cholesterol (- 68%) was shown, whereas changes in HDL3 were less significant (-21%). These findings were confirmed by polyacrylamide gradient gel electrophoresis, typically showing a reduction or disappearance of HDL2b particles and the prevalence of particles in the HDL3a range. Cholesteryl ester transfer from HDL to lower density lipoproteins was significantly increased (30%) in all patients. These findings suggest that, in addition to the well-documented in vitro changes (prevention of LDL peroxidation and macrophage uptake), probucol characteristically modifies HDL particle distribution in vivo, and is associated with a significant increase of cholesteryl ester transfer activity.


This article has been cited by other articles:


Home page
 NEJMHome page
C. R. Sirtori, G. Franceschini, S. J. Jay, D. M. Lisi, G. Cote, J. C. Tardif, and J. Lesperance
Probucol and Multivitamins in the Prevention of Restenosis after Coronary Angioplasty
N. Engl. J. Med., December 25, 1997; 337(26): 1918 - 1919.
[Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Kaneko, J. Hayashi, I. Saito, and N. Miyasaka
Probucol Downregulates E-Selectin Expression on Cultured Human Vascular Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 1047 - 1051.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Murakami, S. Michelagnoli, R. Longhi, G. Gianfranceschi, F. Pazzucconi, L. Calabresi, C. R. Sirtori, and G. Franceschini
Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma
Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1819 - 1828.
[Abstract] [Full Text]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.